Ophthalmic uses of S1P receptor modulators

Details for Australian Patent Application No. 2006222266 (hide)

Owner Novartis AG

Inventors Latour, Elisabeth Jeanne; Lambrou, George N.

Agent Davies Collison Cave

Pub. Number AU-A-2006222266

PCT Pub. Number WO2006/094705

Priority 0504544.8 04.03.05 GB

Filing date 2 March 2006

Wipo publication date 14 September 2006

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094705 Priority application(s): WO2006/094705

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222277-Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism

2006222265-Natural ligand of G protein coupled receptor RCC356 and uses thereof